Argatroban in Thrombocytopenic Patients Sensitized to Circulating Protamine-Heparin Complexes.

[1]  T. Bakchoul,et al.  Protamine (heparin)‐induced thrombocytopenia: a review of the serological and clinical features associated with anti‐protamine/heparin antibodies , 2016, Journal of thrombosis and haemostasis : JTH.

[2]  K. Selleng,et al.  Heparin-induced thrombocytopenia in cardiac surgery and critically ill patients , 2016, Thrombosis and Haemostasis.

[3]  P. Grieshaber,et al.  Platelet-activating protamine-heparin-antibodies lead to higher protamine demand in patients undergoing cardiac surgery. , 2015, The Journal of thoracic and cardiovascular surgery.

[4]  B. Steinlechner,et al.  Serological features of antibodies to protamine inducing thrombocytopenia and thrombosis , 2015, Clinical chemistry and laboratory medicine.

[5]  Y. Gruel,et al.  Incidence of antibodies to protamine sulfate/heparin complexes in cardiac surgery patients and impact on platelet activation and clinical outcome , 2013, Thrombosis and Haemostasis.

[6]  T. Kohlmann,et al.  Anti-protamine-heparin antibodies: incidence, clinical relevance, and pathogenesis. , 2013, Blood.

[7]  J. Kelton,et al.  Nonheparin anticoagulants for heparin-induced thrombocytopenia. , 2013, The New England journal of medicine.

[8]  J. Bartholomew,et al.  Protamine‐induced immune thrombocytopenia , 2013, Transfusion.

[9]  T. Ortel,et al.  High incidence of antibodies to protamine and protamine/heparin complexes in patients undergoing cardiopulmonary bypass. , 2012, Blood.

[10]  Adam Cuker,et al.  Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis. , 2012, Blood.

[11]  Christopher A. Paciullo,et al.  Recognition of heparin-induced thrombocytopenia and initiation of argatroban therapy after cardiothoracic surgery in the intensive care unit. , 2012, The Journal of thoracic and cardiovascular surgery.

[12]  A. Dans,et al.  Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[13]  T. Ortel,et al.  Heparin modifies the immunogenicity of positively charged proteins. , 2010, Blood.

[14]  C. Sigouin,et al.  Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin‐induced thrombocytopenia in two clinical settings , 2006, Journal of thrombosis and haemostasis : JTH.

[15]  P. Boutouyrie,et al.  Diagnostic score for heparin‐induced thrombocytopenia after cardiopulmonary bypass , 2004, Journal of thrombosis and haemostasis : JTH.

[16]  J. Carr,et al.  The heparin-protamine interaction. A review. , 1999, The Journal of cardiovascular surgery.

[17]  G. Blaise.  Heparin and protamine interaction , 1998, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[18]  J. Comstock,et al.  Protamine antibody production in diabetic subjects treated with NPH insulin. , 1990, The American journal of the medical sciences.

[19]  H. Al-Mondhiry,et al.  Protamine-Induced Thrombocytopenia and Leukopenia , 1985, Thrombosis and Haemostasis.